| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
KAZIMI A J |
Director
Officer
10% Owner
|
2025-12-17 |
L - A |
10 |
3.65 |
36.50 |
5,701,083 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Krogulski Kenneth |
Director
|
2025-12-17 |
L - A |
67 |
3.65 |
244.55 |
296,037 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Jones James |
Director
|
2025-12-17 |
L - A |
10 |
3.65 |
36.50 |
44,991 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Jones James |
Director
|
2025-12-16 |
L - A |
14 |
3.27 |
45.78 |
44,981 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
KAZIMI A J |
Director
Officer
10% Owner
|
2025-12-16 |
L - A |
14 |
3.27 |
45.78 |
5,701,073 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Krogulski Kenneth |
Director
|
2025-12-16 |
L - A |
104 |
3.27 |
340.08 |
295,970 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Krogulski Kenneth |
Director
|
2025-12-16 |
L - A |
104 |
3.27 |
340.08 |
295,970 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
KAZIMI A J |
Director
Officer
10% Owner
|
2025-12-16 |
L - A |
14 |
3.27 |
45.78 |
5,701,073 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Jones James |
Director
|
2025-12-16 |
L - A |
14 |
3.27 |
45.78 |
44,981 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Young Caroline |
Director
|
2025-12-16 |
L - A |
3 |
3.27 |
9.81 |
33,284 |
| NONE |
Stellus Private Credit BDC |
Legacy Knight Strategic Opportunities Fund - SCM Series |
10% Owner
|
2025-12-16 |
P - A |
56,624 |
15.26 |
864,082.24 |
1,102,747 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Young Caroline |
Director
|
2025-12-16 |
L - A |
3 |
3.27 |
9.81 |
33,284 |
| NONE |
Stellus Private Credit BDC |
Legacy Knight Strategic Opportunities Fund - SCM Series |
10% Owner
|
2025-12-16 |
P - A |
56,624 |
15.26 |
864,082.24 |
1,102,747 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - D |
2,800 |
0.00 |
0.00 |
1,279,870 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - A |
2,800 |
0.00 |
0.00 |
398,563 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - D |
2,800 |
0.00 |
0.00 |
395,763 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - D |
2,800 |
0.00 |
0.00 |
1,279,870 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - A |
2,800 |
0.00 |
0.00 |
398,563 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
G - D |
2,800 |
0.00 |
0.00 |
395,763 |
| MIST |
Milestone Pharmaceuticals Inc. |
Bharucha David |
|
2025-12-15 |
S - D |
58,007 |
2.32 |
134,576.24 |
105,326 |
| MIST |
Milestone Pharmaceuticals Inc. |
Hasija Amit |
|
2025-12-15 |
S - D |
58,007 |
2.32 |
134,576.24 |
91,993 |
| MIST |
Milestone Pharmaceuticals Inc. |
Oliveto Joseph |
|
2025-12-15 |
S - D |
133,054 |
2.32 |
308,685.28 |
450,667 |
| MIST |
Milestone Pharmaceuticals Inc. |
Muller Lorenz |
|
2025-12-15 |
S - D |
53,566 |
2.32 |
124,273.12 |
196,486 |
| MIST |
Milestone Pharmaceuticals Inc. |
Hasija Amit |
|
2025-12-15 |
S - D |
58,007 |
2.32 |
134,576.24 |
91,993 |
| MIST |
Milestone Pharmaceuticals Inc. |
Bharucha David |
|
2025-12-15 |
S - D |
58,007 |
2.32 |
134,576.24 |
105,326 |